StockData
Artiva Biotherapeutics, Inc. logo

Artiva Biotherapeutics, Inc. (ARTV) stock

ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.77−0.09 (-2.33%)

Close on Nov 18, 2026Market cap $184.32MP/E –Yield –

Artiva Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Artiva Biotherapeutics's market cap was $115.13M on Nov 11, 2026, against $68.14M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$115.13M+325.0%
2025Jan 31, 2025$27.09M-49.6%
2024Dec 31, 2024$53.74M–

More Artiva Biotherapeutics figures

See a number that looks wrong?